Real-time enrollment status for this locally advanced or metastatic er+ her2- breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:51 AM UTC
| NCT Number | NCT04606446 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic ER+ HER2- Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 13, 2026: Clinical trial NCT04606446 is currently recruiting participants. This clinical trial study for locally advanced or metastatic er+ her2- breast cancer is actively seeking new participants at 23 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04606446 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04606446 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.